In July 2022, as per the IQVIA fact sheet, its Data Query System (DQS) used master data management in a highly robust, searchable data repository that enables sponsors and CROs to find better-matched investigators and sites for their clinical trials and better support study planning.
Moreover, according to National Center for Science and Engineering Statistics (NCSES) data, in 2020, the United States spent USD 538 billion on research and development performance increased by 9.1% compared to spending in 2019.
Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/north-america-eclinical-solutions-market
Data Bridge Market Research analyzes that the North America E-Clinical Solutions Market is expected to grow at a CAGR of 14.5% in the forecast period of 2023 to 2030 and is expected to reach USD 20,022.42 million by 2030. Electronic data capture and clinical data management systems are projected to propel the growth of the market as they are widely used in e-clinical solutions for collecting clinical trial data and analyzing medical data electronically.
Key Findings of the Study
The Growing Usage of E-Clinical Solutions in Clinical Trials
Clinical trial is the investigation procedure used to study drug development to assess the safety and efficacy of the molecule. The clinical trial is an extensive and complicated process that has raised the demand for an innovative and automated electronic solution to simplify and reduce clinical trial durations. Researchers and manufacturers developed automated electronic methods to provide assessment in clinical trial management systems.
The e-clinical solutions comprise electronic health records, electronic consent forms, integrating e-technologies, electronic data capture, and clinical data management systems. The e-Clinical solutions are helping researchers in end-to-end clinical research processes by providing solutions, through proper management of lengthy clinical research processes. It helps clinical research organizations with regulatory document management, team collaboration and management of supply chains, site performance management, and reporting, which is increasing demand for e-Clinical solutions in the market.
The e-clinical solutions have helped doctors and researchers to reduce the clinical trial cost and duration, and to collect data.
Thus, to reduce the chance of data loss and increase the number of clinical trials, which is increasing the usage of e-clinical solutions in clinical trials.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product (Electronic Data Capture and Clinical Trial Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Care Coordination Medical Records (CCMR), Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premises) Solutions, and Cloud-Based (SAAS) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Small & Medium and Large), User Device (Desktop, Tablet, Handheld PDA Device, Smart Phone, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutes)
|
|
Countries Covered
|
U.S., Canada, and Mexico
|
|
Market Players Covered
|
Oracle (U.S.), Signant Health (U.S.), MaxisIT (U.S.), Paraxel International Corporation (U.S.), Dassault Systemes (France), Clario (U.S.), Mednet (U.S.), OpenClinica, LLC (U.S.), 4G Clinical (U.S.), Veeva Systems (U.S.), Saama Technologies, LLC (U.S.), Anju (U.S.), Castor, Medrio, Inc. (U.S.), ArisNorth America (U.S.), Merative (U.S.), Advarra (U.S.), eClinical Solutions, LLC (U.S.), Y-Prime LLC (U.S.), RealTime Software Solutions LLC (U.S.), Datatrak Int. (U.S.), and IQVIA Inc. (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The North America e-clinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, organization size, user device, and end user.
- On the basis of product, the market is segmented into electronic data capture and clinical trial data management systems, clinical trial management systems, clinical analytics platforms, care coordination medical records (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions, and others.
In 2023, the electronic data capture and clinical trial data management systems segment is expected to dominate the market
In 2023, the electronic data capture and clinical trial data management systems segment is expected to dominate the market with a market share of 24.14%, due to growing awareness about the advantages of EDC services over paper-based clinical information management.
- On the basis of delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.
In 2023, the web-hosted (on-demand) solutions segment is expected to dominate the market
In 2023, the web-hosted (on-demand) solutions segment is expected to dominate the market with a market share of 42.70%, due to the advancements and innovation in the approaches of e-clinical solutions.
- On the basis of clinical trial phase, the market is segmented into phase I, phase II, phase III, and phase IV. In 2023, the phase III segment is expected to dominate the market with a market share of 39.05%.
- On the basis of organization size, the market is segmented into small and medium and large. In 2023, the small and medium segment is expected to dominate the market with a market share of 63.10% market share.
- On the basis of user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others. In 2023, the desktop segment is expected to dominate the market with a market share of 50.18%.
- On the basis of end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes. In 2023, the contract research organizations segment is expected to dominate the market with a market share of 41.08%.
Major Players
Data Bridge Market Research recognizes the following companies as the major e-Clinical solutions market players in North America e-clinical solutions market are Oracle (U.S.), Signant Health (U.S.), MaxisIT (U.S.), Paraxel International Corporation (U.S.), Dassault Systemes (France), Clario (U.S.), Mednet (U.S.), OpenClinica, LLC (U.S.), 4G Clinical (U.S.), Veeva Systems (U.S.), Saama Technologies, LLC (U.S.), Anju (U.S.), Castor, Medrio, Inc. (U.S.), ArisNorth America (U.S.), Merative (U.S.), Advarra (U.S.), eClinical Solutions, LLC (U.S.), Y-Prime LLC (U.S.), RealTime Software Solutions LLC (U.S.), Datatrak Int. (U.S.), and IQVIA Inc. (U.S.) among others.
Market Development
- In April 2023, Oracle as a leading supplier of operational and clinical technology for hospitals and healthcare systems globally, Oracle, Deloitte today announced the extension of its operating system for the healthcare industry to include implementing, operating, and advisory services for Oracle. Deloitte's growing portfolio of healthcare technology products, Deloitte Health-Oracle Accelerated, is created to keep up with the industry's transformation into a vast ecosystem and platform driven by patients rather than hospitals, providers, or insurance companies. Deloitte, a long-standing Oracle PartnerNetwork (OPN) member, is collaborating with Oracle Health to provide clients with a healthcare delivery system that is prepared for the future.
- In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights, will further improve clinical trial productivity. This has aided the business in promoting its offerings across the region as well as globally.
- In March 2023, Clario launched a cloud-based Image Viewer tool that helps the sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering.
- In July 2022, Advarra launched a cloud-based secure document exchange to accelerate study startup. This helped the company to establish its global presence.
- In November 2022, Veeva Systems and Merck, known as MSD outside of the United States and Canada, announced a ten-year strategic partnership agreement to expand on their current 12-year cooperation. Per the contract's conditions, Merck will prioritize Veeva's integrated, cloud-based platform and products when developing new industry-specific software and data, choosing Veeva solutions when appropriate. Merck will receive input into Veeva's product development and a strategic pricing approach from Veeva. The collaboration speeds up Merck's digital strategy and improves the company's ability to analyze, acquire, use, and get value from Veeva goods and services.
Regional Analysis
Geographically, the countries covered in the advanced wound care market report are U.S., Canada and Mexico
As per Data Bridge Market Research analysis:
U.S. is the dominant and fastest country in the market during the forecast period 2023 - 2030.
U.S. is expected to dominate the market owing to the higher level of investments by U.S. manufacturers and increasing adoption of e-Clinical solutions. U.S. will continue to dominate the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and the launch of new e-Clinical solutions products in this region. In addition, an increase in the number of clinical studies for drug development and discovery, and is anticipated to propel the demand for EDC systems in this region.
U.S. is expected to grow during the forecast period due to the rapid development of medical facilities in emerging economies in this region. In addition to this, rising levels of healthcare expenditure and increasing per-capita income are expected to propel the market's growth rate in this region.
For more detailed information about the the North America e-clinical solutions market report, click here – https://www.databridgemarketresearch.com/jp/reports/north-america-eclinical-solutions-market
